Natural Products and Phytochemicals in Modern Drug Discovery: Mechanistic Insights, Barriers, and Future Opportunities

Abstract

Natural products have long been central to therapeutic development, offering structurally diverse compounds that continue to inspire modern drug discovery. Phytochemicals including polyphenols, flavonoids, terpenoids, and alkaloids exert multi-target actions that regulate oxidative stress, inflammation, apoptosis, and immune and metabolic pathways. These pleiotropic effects make them promising candidates for treating complex, multifactorial diseases such as cancer, cardiovascular disorders, diabetes, and neurodegenerative conditions. Despite their therapeutic potential, the clinical progression of natural products is restricted by poor solubility, low bioavailability, metabolic instability, and variability arising from environmental and seasonal factors. Limited standardization and insufficient large-scale clinical trials further impede regulatory approval.Recent technological advances are helping overcome these limitations. Modern extraction techniques, advanced chromatographic and spectroscopic profiling, structural modification strategies, nanocarrier-based delivery systems, and synthetic biology platforms have improved the stability, yield, and pharmacokinetic performance of natural compounds. Omics-driven analyses and computational modelling have enhanced understanding of molecular mechanisms and facilitated more efficient identification and optimization of bioactive leads.By integrating traditional pharmacognosy with emerging scientific innovations, natural products and phytochemicals remain vital contributors to future drug discovery, offering sustainable, mechanistically rich, and clinically relevant avenues for therapeutic development.